MANF Human

Mesencephalic Astrocyte-Derived Neurotrophic Factor Human Recombinant
Cat. No.
BT9252
Source
Escherichia Coli.
Synonyms
Mesencephalic astrocyte-derived neurotrophic factor, Protein ARMET, ARP, arginine-rich mutated in early stage tumors, Arginine-rich protein.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

MANF Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 158 amino acids and having a molecular mass of 18.1 kDa.
The MANF is purified by proprietary chromatographic techniques.

Product Specs

Introduction
MANF, a 20kDa protein belonging to the ARMET family, was initially identified as an arginine-rich region protein frequently mutated in various tumors. Its expression increases during ER stress, suggesting a role in protein quality control under such conditions.
Description
Recombinant human MANF, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 158 amino acids. With a molecular weight of 18.1 kDa, it undergoes purification using proprietary chromatographic techniques.
Physical Appearance
White, sterile-filtered powder in lyophilized (freeze-dried) form.
Formulation
Subjected to filtration (0.2 µm) and lyophilization from a concentrated solution (1 mg/ml) in 1x PBS at pH 7.4.
Solubility
For reconstitution, dissolve the lyophilized MANF in sterile 18 MΩ·cm H2O at a concentration of at least 100 µg/ml. This solution can be further diluted in other aqueous solutions.
Stability
While lyophilized MANF remains stable at room temperature for up to 3 weeks, storage in a desiccated state below -18°C is recommended. After reconstitution, store MANF at 4°C for 2-7 days. For long-term storage, keep it below -18°C. Adding a carrier protein (0.1% HSA or BSA) is advisable for extended storage. Avoid repeated freeze-thaw cycles.
Purity
Exceeds 95.0%, as determined by: (a) RP-HPLC analysis, (b) SDS-PAGE analysis.
Biological Activity
The half-maximal effective concentration (ED50) is typically in the range of 15-25 µg/ml. This was established based on its capacity to promote the proliferation of rat C6 cells.
Synonyms
Mesencephalic astrocyte-derived neurotrophic factor, Protein ARMET, ARP, arginine-rich mutated in early stage tumors, Arginine-rich protein.
Source
Escherichia Coli.
Amino Acid Sequence
LRPGDCEVCI SYLGRFYQDL KDRDVTFSPA TIENELIKFC REARGKENRL CYYIGATDDA ATKIINEVSK PLAHHIPVEK ICEKLKKKDS QICELKYDKQ IDLSTVDLKK LRVKELKKIL DDWGETCKGC AEKSDYIRKI NELMPKYAPK AASARTDL.

Product Science Overview

Introduction

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) is a protein that has garnered significant interest in the field of neurobiology due to its unique properties and potential therapeutic applications. Initially derived from a rat mesencephalic type-1 astrocyte cell line, MANF is known for its ability to selectively protect dopaminergic neurons, which are crucial for motor control and are affected in diseases like Parkinson’s .

Structure and Function

MANF is an arginine-rich protein that is encoded by the MANF gene. It is localized in the endoplasmic reticulum (ER) and Golgi apparatus, and it is also secreted extracellularly . The protein plays a critical role in promoting the survival of dopaminergic neurons and modulating GABAergic transmission to these neurons . Additionally, MANF inhibits cell proliferation and protects against ER stress-induced cell death .

Expression and Regulation

In the uninjured brain, MANF is predominantly expressed in neurons. However, its expression pattern changes significantly in response to injury. For instance, in ischemic stroke models, MANF expression shifts from neurons to inflammatory cells such as microglia and macrophages . This transition suggests that MANF may play a role in regulating post-stroke inflammation and promoting tissue recovery .

Therapeutic Potential

Recombinant human MANF has shown promising results in various experimental models. In a rat model of cortical ischemic stroke, systemic delivery of recombinant MANF reduced infarct volume and improved neurological outcomes . Intranasal and intravenous administration of recombinant MANF also demonstrated anti-inflammatory effects, such as decreasing pro-inflammatory cytokines and increasing anti-inflammatory cytokines like IL-10 .

Clinical Implications

The therapeutic potential of MANF extends beyond stroke. It has been implicated in various diseases, including diabetes, deafness, developmental delay, and short stature syndrome . The protein’s ability to modulate ER stress and promote cell survival makes it a promising candidate for treating neurodegenerative diseases and other conditions characterized by cellular stress and inflammation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.